Instituto Rosenbusch

Instituto Rosenbusch Book Value Growth

The Book Value Growth of Instituto Rosenbusch (ROSE2.BA) as of Nov 16, 2026 is -121.40 %. In the previous year, Book Value Growth was -10.31 % — a change of 1,077.39% (lower).

Book Value Growth

-121.40 %

YoY

1,077.39%

Last updated:

Book Value Growth of Instituto Rosenbusch is 2025 -121.40 % . Book Value Growth of Instituto Rosenbusch was 2024 -10.31 % . It decreases by 1,077.39% lower compared to the previous year.

The Instituto Rosenbusch Book Value Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value Growth
Date
Book Value Growth
Jan 1, 2018
65.64 ARS
Jan 1, 2019
-17.94 ARS
Jan 1, 2020
24.16 ARS
Jan 1, 2021
36.02 ARS
Jan 1, 2022
104.95 ARS
Jan 1, 2023
1,049.12 ARS
Jan 1, 2024
-10.31 ARS
Jan 1, 2025
-121.40 ARS
The Instituto Rosenbusch Book Value Growth history
YEARBook Value GrowthYoY
-121.40 %+1,077.39%
-10.31 %-100.98%
1,049.12 %+899.64%
104.95 %+191.38%
36.02 %+49.06%
24.16 %-234.72%
-17.94 %-127.32%
65.64 %+3,564.52%
1.79 %-89.59%
17.21 %+1,706.42%
0.95 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Instituto Rosenbusch Stock analysis

What does Instituto Rosenbusch do? Instituto Rosenbusch SA generates revenue through the manufacture and marketing of veterinary pharmaceuticals and biological products. The company's Pharmaceutical line includes antibiotics, antimastitics, antimycotics, antiparasites, vitamins, minerals, and other chemotherapies, while its Biological line comprises vaccines for cattle, equines, porks, sheeps, and dogs. The firm also earns income from slaughtering and providing meat products. Subsidiaries such as Laboratorios Rosenbusch SA, Laboratorios Bolivar SA, and Rosenbusch Paraguay SA contribute to the company's operations and revenue streams. The primary customers for veterinary pharmaceuticals are livestock farmers and veterinarians, while meat products are sold to consumers and food retailers. The company's product segments are clearly defined by their categories: Pharmaceutical for animal health treatments and Biological for disease prevention through vaccines. Meat provision targets the broader food market, extending the company's reach beyond veterinary services. Institutional buyers of veterinary products include farms and veterinary clinics, which purchase antibiotics, vaccines, and other treatments. The meat segment serves retail and wholesale food markets, with subsidiaries supporting production and distribution. The company's focus on both animal health and meat provision creates a diversified revenue model, leveraging its subsidiaries for expanded market coverage. Instituto Rosenbusch is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Instituto Rosenbusch stock

Book Value Growth of Instituto Rosenbusch is -121.40 % in 2025.

On Eulerpool you can find the complete historical development of Book Value Growth Instituto Rosenbusch since 2006 – with annual values, charts, and detailed analysis.

Book value growth measures the percentage increase in shareholders' equity. It indicates how effectively the company retains and grows its net assets.

To evaluate Book Value Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Book Value Growth.

Book Value Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Book Value Growth's Instituto Rosenbusch historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Instituto Rosenbusch

All Key Metrics — Instituto Rosenbusch